Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Analysis of the Second Year of Safety Surveillance of the Qdenga® (TAK-003) Vaccine in Private Vaccination Centers, Including a Sub-analysis of Safety in Adults Over 60 Years of Age

NCT07812142 is registered in ClinicalTrials.gov with Fundación Vacunar as lead sponsor.

NCT NCT07812142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07812142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Analysis of the Second Year of Safety Surveillance of the Qdenga® (TAK-003) Vaccine in Private Vaccination Centers, Including a Sub-analysis of Safety in Adults Over 60 Years of Age
Lead sponsor
Fundación Vacunar
Phase
Observational
Overall status
Active, not recruiting
Start date
November 2, 2024
Completion date
December 1, 2026
Enrollment
94,526 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dengue vaccines